Correlation Between Mineralys Therapeutics, and Gilead Sciences
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Gilead Sciences, you can compare the effects of market volatilities on Mineralys Therapeutics, and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Gilead Sciences.
Diversification Opportunities for Mineralys Therapeutics, and Gilead Sciences
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mineralys and Gilead is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Gilead Sciences go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Gilead Sciences
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Gilead Sciences. In addition to that, Mineralys Therapeutics, is 2.76 times more volatile than Gilead Sciences. It trades about -0.03 of its total potential returns per unit of risk. Gilead Sciences is currently generating about 0.12 per unit of volatility. If you would invest 8,808 in Gilead Sciences on August 30, 2024 and sell it today you would earn a total of 433.00 from holding Gilead Sciences or generate 4.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Gilead Sciences
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Gilead Sciences |
Mineralys Therapeutics, and Gilead Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Gilead Sciences
The main advantage of trading using opposite Mineralys Therapeutics, and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.| Mineralys Therapeutics, vs. Evolution Gaming Group | Mineralys Therapeutics, vs. Mativ Holdings | Mineralys Therapeutics, vs. CF Industries Holdings | Mineralys Therapeutics, vs. The Mosaic |
| Gilead Sciences vs. Ikena Oncology | Gilead Sciences vs. Eliem Therapeutics | Gilead Sciences vs. HCW Biologics | Gilead Sciences vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |